Xamron Tablet contains Ramosetron 5 mcg, a selective serotonin 5-HT3 receptor antagonist primarily used to prevent nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative conditions. Ramosetron exerts its antiemetic effect by blocking serotonin receptors in the central nervous system and gastrointestinal tract, thereby inhibiting the activation of the vomiting reflex. This medication is indicated for the management of acute and delayed chemotherapy-induced nausea and vomiting (CINV), as well as for the prevention of postoperative nausea and vomiting (PONV). Xamron Tablet is administered orally and is well absorbed, with a favorable safety profile. Common adverse effects may include headache, constipation, and fatigue, but serious side effects are rare. It should be used with caution in patients with hepatic impairment or a history of hypersensitivity to 5-HT3 antagonists. Dosage adjustments may be necessary based on clinical response and patient tolerance. Xamron Tablet should be used under medical supervision, and patients are advised to report any unusual symptoms promptly. This medication offers an effective therapeutic option for improving patient comfort and compliance during treatments known to cause emesis.